In this context, it is worth noting the finding of a post-genetic mechanism allowing the tight control of post-transcriptionally expressed EphB4 protein levels via an autocrine signal specifically conveyed by cancer secreted IGF-II and targeting EphB4 via a newly phospho-degron domain, ultimately skipping transcriptional control to allow cellular hyperexpression [7]. This evidence concerns the gene EPHB4 and cancer.